Dementia praecox redux: A systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dementia praecox redux: A systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 29, Issue 2, Pages 197-211
Publisher
SAGE Publications
Online
2015-01-08
DOI
10.1177/0269881114564096
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Merging old and new perspectives on nicotinic acetylcholine receptors
- (2014) Roger L. Papke BIOCHEMICAL PHARMACOLOGY
- Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer’s disease dementia
- (2014) Michel J. Grothe et al. JOURNAL OF NEUROLOGY
- Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition
- (2014) SHELDON H. PRESKORN et al. Journal of Psychiatric Practice
- Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia
- (2014) J Kuhn et al. MOLECULAR PSYCHIATRY
- Striatal Cholinergic Interneurons Drive GABA Release from Dopamine Terminals
- (2014) Alexandra B. Nelson et al. NEURON
- The role of nicotinic receptors in shaping and functioning of the glutamatergic system: A window into cognitive pathology
- (2014) Susanna Molas et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Special Section on Implications of CATIE: What CATIE Found: Results From the Schizophrenia Trial
- (2014) Marvin S. Swartz et al. PSYCHIATRIC SERVICES
- Development of M1 mAChR Allosteric and Bitopic Ligands: Prospective Therapeutics for the Treatment of Cognitive Deficits
- (2013) Briana J. Davie et al. ACS Chemical Neuroscience
- Biogenesis, trafficking and up-regulation of nicotinic ACh receptors
- (2013) Sara Francesca Colombo et al. BIOCHEMICAL PHARMACOLOGY
- Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia
- (2013) Jared W. Young et al. BIOCHEMICAL PHARMACOLOGY
- Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies
- (2013) Anshul A. Pandya et al. BIOCHEMICAL PHARMACOLOGY
- The Ascending Mesolimbic Cholinergic System—A Specific Division of the Reticular Activating System Involved in the Initiation of Negative Emotional States
- (2013) Stefan M. Brudzynski JOURNAL OF MOLECULAR NEUROSCIENCE
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia
- (2013) A L Guillozet-Bongaarts et al. MOLECULAR PSYCHIATRY
- Pedunculopontine nucleus: Functional organization and clinical implications
- (2013) E. E. Benarroch NEUROLOGY
- A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia
- (2013) Jeffrey A Lieberman et al. NEUROPSYCHOPHARMACOLOGY
- Towards improved animal models for evaluating social cognition and its disruption in schizophrenia: The CNTRICS initiative
- (2013) Mark J. Millan et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Harnessing cognitive neuroscience to develop new treatments for improving cognition in schizophrenia: CNTRICS selected cognitive paradigms for animal models
- (2013) Holly Moore et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia
- (2013) Sungwon Roh et al. PSYCHOPHARMACOLOGY
- A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia
- (2013) Maryam Noroozian et al. PSYCHOPHARMACOLOGY
- The nicotinergic receptor as a target for cognitive enhancement in schizophrenia: Barking up the wrong tree?
- (2013) C. Quisenaerts et al. PSYCHOPHARMACOLOGY
- Targeting alpha-7 nicotinic neurotransmission in schizophrenia: A novel agonist strategy
- (2013) Stephen I. Deutsch et al. SCHIZOPHRENIA RESEARCH
- Schizophrenia Is a Cognitive Illness
- (2013) René S. Kahn et al. JAMA Psychiatry
- Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What’s the Evidence?
- (2013) Wilhelmina A. M. Vingerhoets et al. Frontiers in Psychiatry
- Cognitive Impairment Associated with Schizophrenia: A Review of the Humanistic Burden
- (2012) Helen Kitchen et al. ADVANCES IN THERAPY
- Short-Term Tropisetron Treatment and Cognitive and P50 Auditory Gating Deficits in Schizophrenia
- (2012) Xiang Yang Zhang et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence
- (2012) Mario Fioravanti et al. BMC Psychiatry
- Novel M1allosteric ligands: a patent review
- (2012) Scott D Kuduk et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Ropinirole as an Effective Adjunctive Treatment for Clozapine-Resistant Negative Symptoms in Simple Schizophrenia
- (2012) Panayiota G. Michalopoulou et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Neurocognitive Outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study
- (2012) Jean A. Frazier et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?
- (2012) S Kapur et al. MOLECULAR PSYCHIATRY
- Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap
- (2012) Judith Pratt et al. NATURE REVIEWS DRUG DISCOVERY
- Cholinergic depletion in nucleus accumbens impairs mesocortical dopamine activation and cognitive function in rats
- (2012) François Laplante et al. NEUROPHARMACOLOGY
- Leveraging the cortical cholinergic system to enhance attention
- (2012) Elise Demeter et al. NEUROPHARMACOLOGY
- Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: A proof-of-mechanism study
- (2012) Georg Winterer et al. NEUROPHARMACOLOGY
- CNTRICS final animal model task selection: Control of attention
- (2012) C. Lustig et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Measuring the construct of executive control in schizophrenia: Defining and validating translational animal paradigms for discovery research
- (2012) Gary Gilmour et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Nicotinic acetylcholine receptors: From basic science to therapeutics
- (2012) Raymond Hurst et al. PHARMACOLOGY & THERAPEUTICS
- Defining treatment-resistant schizophrenia and response to antipsychotics: A review and recommendation
- (2012) Takefumi Suzuki et al. PSYCHIATRY RESEARCH
- Impact of Neurocognition on Social and Role Functioning in Individuals at Clinical High Risk for Psychosis
- (2011) Ricardo E. Carrión et al. AMERICAN JOURNAL OF PSYCHIATRY
- A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia
- (2011) Victoria C. Wing et al. Annals of the New York Academy of Sciences
- Allosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors
- (2011) Anshul Pandya et al. BIOCHEMICAL PHARMACOLOGY
- Translating cognition from animals to humans
- (2011) J.F. Keeler et al. BIOCHEMICAL PHARMACOLOGY
- Naturally-expressed nicotinic acetylcholine receptor subtypes
- (2011) Jie Wu et al. BIOCHEMICAL PHARMACOLOGY
- Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease
- (2011) Tanya L. Wallace et al. BIOCHEMICAL PHARMACOLOGY
- Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia
- (2011) Jill M. Williams et al. DRUG AND ALCOHOL DEPENDENCE
- GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons
- (2011) Daniel F English et al. NATURE NEUROSCIENCE
- Timing-Dependent Septal Cholinergic Induction of Dynamic Hippocampal Synaptic Plasticity
- (2011) Zhenglin Gu et al. NEURON
- Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
- (2011) Joo-Cheol Shim et al. NEUROPSYCHOPHARMACOLOGY
- Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia
- (2011) Carrie K Jones et al. NEUROPSYCHOPHARMACOLOGY
- Cognitive enhancers for the treatment of ADHD
- (2011) L. Cinnamon Bidwell et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Imaging Biomarkers for Treatment Development for Impaired Cognition: Report of the Sixth CNTRICS Meeting: Biomarkers Recommended for Further Development
- (2011) C. S. Carter et al. SCHIZOPHRENIA BULLETIN
- Neurocognitive Predictors of Work Outcome in Recent-Onset Schizophrenia
- (2011) K. H. Nuechterlein et al. SCHIZOPHRENIA BULLETIN
- The cholinergic system and hippocampal plasticity
- (2010) Benjamin D. Drever et al. BEHAVIOURAL BRAIN RESEARCH
- Key role of striatal cholinergic interneurons in processes leading to arrest of motor stereotypies
- (2010) Verena Aliane et al. BRAIN
- Why do patients with schizophrenia smoke?
- (2010) Georg Winterer CURRENT OPINION IN PSYCHIATRY
- Nicotine and cotinine increases the brain penetration of saquinavir in rat
- (2010) Vamshi K. Manda et al. JOURNAL OF NEUROCHEMISTRY
- Allosteric modulation of metabotropic glutamate receptors: Structural insights and therapeutic potential
- (2010) Karen J. Gregory et al. NEUROPHARMACOLOGY
- Modes and Models of Forebrain Cholinergic Neuromodulation of Cognition
- (2010) Michael E Hasselmo et al. NEUROPSYCHOPHARMACOLOGY
- CaMKII control of spine size and synaptic strength: Role of phosphorylation states and nonenzymatic action
- (2010) H. J. Pi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Premorbid tobacco smoking is associated with later age at onset in schizophrenia
- (2010) Xiaohong Ma et al. PSYCHIATRY RESEARCH
- Meta-analysis of the acute effects of nicotine and smoking on human performance
- (2010) Stephen J. Heishman et al. PSYCHOPHARMACOLOGY
- Report From the Working Group Conference on Multisite Trial Design for Cognitive Remediation in Schizophrenia
- (2010) R. S. E. Keefe et al. SCHIZOPHRENIA BULLETIN
- Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia
- (2010) Jean-Pierre Lindenmayer et al. SCHIZOPHRENIA RESEARCH
- Cognition at illness onset as a predictor of later functional outcome in early psychosis: Systematic review and methodological critique
- (2010) Kelly Allott et al. SCHIZOPHRENIA RESEARCH
- A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
- (2010) Akihiro Shiina et al. Annals of General Psychiatry
- Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)
- (2009) Michael Davidson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Dendritic spine formation and stabilization
- (2009) Yoshihiro Yoshihara et al. CURRENT OPINION IN NEUROBIOLOGY
- Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic Smokers
- (2009) Sharon Mexal et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Activation and Desensitization of Nicotinic 7-type Acetylcholine Receptors by Benzylidene Anabaseines and Nicotine
- (2009) R. L. Papke et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Atypical antipsychotics as noncompetitive inhibitors of α4β2 and α7 neuronal nicotinic receptors
- (2009) Vladimir P. Grinevich et al. NEUROPHARMACOLOGY
- A cog in cognition: How the α7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits
- (2009) Steven C. Leiser et al. PHARMACOLOGY & THERAPEUTICS
- Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
- (2009) Edson X. Albuquerque et al. PHYSIOLOGICAL REVIEWS
- Varenicline and P50 auditory gating in medicated schizophrenic patients: A pilot study
- (2009) Merilyne C. Waldo et al. PSYCHIATRY RESEARCH
- Nicotine Enhances but Does Not Normalize Visual Sustained Attention and the Associated Brain Network in Schizophrenia
- (2009) L. E. Hong et al. SCHIZOPHRENIA BULLETIN
- Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
- (2008) Robert Freedman et al. AMERICAN JOURNAL OF PSYCHIATRY
- Rare chromosomal deletions and duplications increase risk of schizophrenia
- (2008) Jennifer L. Stone et al. NATURE
- Selective cholinergic lesions in the rat nucleus basalis magnocellularis with limited damage in the medial septum specifically alter attention performance in the five-choice serial reaction time task
- (2008) H. Harati et al. NEUROSCIENCE
- Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
- (2008) D. Ziedonis et al. NICOTINE & TOBACCO RESEARCH
- Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment
- (2008) Alasdair M. Barr et al. SCHIZOPHRENIA RESEARCH
- High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia
- (2008) M DYER et al. SCHIZOPHRENIA RESEARCH
- Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia
- (2007) Robert W. Buchanan et al. AMERICAN JOURNAL OF PSYCHIATRY
- Muscarinic acetylcholine receptors as CNS drug targets
- (2007) Christopher J. Langmead et al. PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started